$0.0390
At close: May 7, 10:59 AM EDT
Comments
Loading...
Cardiac Biotech Solutions Analyst Ratings and Price Targets | OTC:CBSC | Benzinga
Cardiac Biotech Solutions Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cardiac Biotech Solutions Corp from these most-recent analyst ratings.
Analyst Ratings for Cardiac Biotech Solutions
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Cardiac Biotech Solutions (CBSC) stock?
There is no price target for Cardiac Biotech Solutions
What is the most recent analyst rating for Cardiac Biotech Solutions (CBSC)?
There is no analyst for Cardiac Biotech Solutions
When was the last upgrade for Cardiac Biotech Solutions (CBSC)?
There is no last upgrade for Cardiac Biotech Solutions
When was the last downgrade for Cardiac Biotech Solutions (CBSC)?
There is no last downgrade for Cardiac Biotech Solutions.
When is the next analyst rating going to be posted or updated for Cardiac Biotech Solutions (CBSC)?
There is no next analyst rating for Cardiac Biotech Solutions.
Is the Analyst Rating Cardiac Biotech Solutions (CBSC) correct?
There is no next analyst rating for Cardiac Biotech Solutions.
Browse analyst ratings and price targets on all stocks.
